EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, RXII: Rxi Pharmaceuticals

16 Nov 2018
LAST:

0.3300

CHANGE:
 0.00		OPEN:
0.3300		HIGH:
0.3300		ASK:
0.6900		VOLUME:
461.1K
CHG(%):
0.00		PREV:
0.3300		LOW:
0.3200		BID:
0.4310		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
16 Nov 180.33000.33000.32000.3300461.1K
15 Nov 180.31500.33500.31000.3300948K
14 Nov 180.38000.39000.31000.33002.94M
13 Nov 180.34000.36000.34000.3500824.1K
12 Nov 180.41000.41000.33000.35004.8M
09 Nov 180.48000.48000.42000.43005.25M
08 Nov 180.47000.50000.44000.480010.01M
07 Nov 180.43000.47000.43000.44002.97M
06 Nov 180.43000.46000.42000.4200670.5K
05 Nov 180.42000.44000.42000.4300258K

COMPANY PROFILE

Name:Rxi Pharmaceuticals
About:We were incorporated as Argonaut Pharmaceuticals, Inc. in Delaware on April 3,  2006, changed our name to RXi Pharmaceuticals Corporation on November 28, 2006,  and began operations as a majority-owned subsidiary of CytRx Corporation  (?CytRx?) in January 2007. We are a discovery-stage biopharmaceutical company  pursuing the development and potential commercialization of proprietary  therapeutics based on RNA interference (RNAi) for the treatment of human  diseases. We believe RNAi-based therapeutics have the potential to effectively  treat a broad array of diseases by interfering with (sometimes referred to as  silencing) the expression of targeted disease-associated genes. Our initial  focus is on the treatment of neurological diseases, metabolic diseases and  oncology.  RXi was founded by CytRx and four prominent researchers in the field of RNAi,  including Dr.  ...
Sector:Consumer Durables
Industry:Major Pharmaceuticals
   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

TECHNICALS

MA5:0.34
MA20:0.41
MA50:0.71
MA200:2.02
STO9:11.02
RSI14:44.54
MTM14:-0.08
ROC14:0.80
Week High:0.41
Week Low:0.31
Month High:0.50
Month Low:0.31
Volatility:9.00